Michael R. Sierks

Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases

Stephanie M. Williams, M. Sierks, Stephanie M Williams, 2016, The European journal of neuroscience.

Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples

M. Sierks, S. Emadi, Philip Schulz, 2013, Biotechnology progress.

Residues 17–20 and 30–35 of beta‐amyloid play critical roles in aggregation

Y. Lyubchenko, M. Sierks, Rui-tian Liu, 2004, Journal of neuroscience research.

Artificial Antibodies for Affinity Chromatography of Homologous Proteins: Application to Blood Clotting Proteins

M. Sierks, G. Goud, Huiping Wu, 1998, Biotechnology progress.